ZA913920B - Therapeutic compound - Google Patents

Therapeutic compound

Info

Publication number
ZA913920B
ZA913920B ZA913920A ZA913920A ZA913920B ZA 913920 B ZA913920 B ZA 913920B ZA 913920 A ZA913920 A ZA 913920A ZA 913920 A ZA913920 A ZA 913920A ZA 913920 B ZA913920 B ZA 913920B
Authority
ZA
South Africa
Prior art keywords
therapeutic compound
treatment
bronchitis
ofbronchitis
medicament
Prior art date
Application number
ZA913920A
Other languages
English (en)
Inventor
Mitchell Glass
Glass Mitchell
Joseph Campbell Williams
Campbell Williams Joseph
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of ZA913920B publication Critical patent/ZA913920B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ZA913920A 1990-05-24 1991-05-23 Therapeutic compound ZA913920B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52865790A 1990-05-24 1990-05-24

Publications (1)

Publication Number Publication Date
ZA913920B true ZA913920B (en) 1992-02-26

Family

ID=24106599

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA913920A ZA913920B (en) 1990-05-24 1991-05-23 Therapeutic compound

Country Status (12)

Country Link
EP (1) EP0458537B1 (fr)
JP (1) JPH04235133A (fr)
AT (1) ATE178336T1 (fr)
AU (1) AU648078B2 (fr)
CA (1) CA2043107A1 (fr)
DE (1) DE69131058T2 (fr)
DK (1) DK0458537T3 (fr)
ES (1) ES2129401T3 (fr)
GR (1) GR3029726T3 (fr)
IE (1) IE911698A1 (fr)
IL (1) IL98200A0 (fr)
ZA (1) ZA913920B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis
IE911697A1 (en) * 1990-05-24 1991-12-04 Zeneca Ltd Therapeutic agent
GB9113164D0 (en) * 1991-06-18 1991-08-07 Ici Plc Pharmaceutical agent
DE10138294C5 (de) * 2001-08-10 2006-09-28 Db Netz Ag Verfahren und Vorrichtung zum Auswechseln eines Fahrdrahtes an einer Oberleitung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0182906A1 (fr) * 1984-06-14 1986-06-04 Cortech, Inc. Inhibiteurs d'elastase de leucocytes humains, prepares a partir de bacteries pyogenes et procede de purification de ces substances
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0276101A3 (fr) * 1987-01-19 1989-11-23 Ici Americas Inc. Dérivés de peptides substitués
GB8809316D0 (en) * 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
EP0345906B1 (fr) * 1988-06-10 1996-03-13 Merck & Co. Inc. Antigènes spécifiques du site de coupure unique du fibrinogène par l'élastase
EP0369391A3 (fr) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. Amides N-substitués
NO177716C (no) * 1989-06-09 1995-11-08 Zeneca Ltd Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis

Also Published As

Publication number Publication date
JPH04235133A (ja) 1992-08-24
DE69131058T2 (de) 1999-09-09
ATE178336T1 (de) 1999-04-15
DK0458537T3 (da) 1999-10-18
ES2129401T3 (es) 1999-06-16
EP0458537A3 (en) 1992-07-08
AU648078B2 (en) 1994-04-14
GR3029726T3 (en) 1999-06-30
IL98200A0 (en) 1992-06-21
EP0458537B1 (fr) 1999-03-31
IE911698A1 (en) 1991-12-04
CA2043107A1 (fr) 1991-11-25
AU7719491A (en) 1991-11-28
EP0458537A2 (fr) 1991-11-27
DE69131058D1 (de) 1999-05-06

Similar Documents

Publication Publication Date Title
TW249226B (fr)
GB8806737D0 (en) Therapeutic composition & method
GR3020902T3 (en) Use of 15-keto-prostaglandin compound for improvement of encephalic function
IL97426A0 (en) 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions
AU6857887A (en) Therapeutic agent
ZA892449B (en) Topical preparation for treating otopathy
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
EP0467564A3 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
GR3018674T3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
GR3026105T3 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
GR3018651T3 (en) Treatment of ocular hypertention with a synergistic combination
AU569354B2 (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
EP0458537A3 (en) Therapeutic compound for the treatment of bronchitis
EP0430552A3 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
WO1991015466A3 (fr) Agents chelateurs
EP0454429A3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
EP0469782A3 (en) Treatment of cataract with prostacyclin compounds
AU7719591A (en) Therapeutic agent
AU5199286A (en) New use of 1,4-dihydropyridine derivatives
IE882864L (en) Glaucoma treatment